摘要
背景:植物乳蓟和水飞蓟素传统上被用作治疗各种疾病的天然补救剂已有2000多年的历史,包括神经系统疾病如阿尔茨海默氏症,帕金森病和脑缺血症。 目的:在本文中,我们回顾了水飞蓟素对各种神经功能障碍的神经保护作用。 结果:水飞蓟素赋予的神经保护作用包括调节各种抗氧化机制,以及涉及细胞信号传导途径的几种激酶,抑制神经变性期间产生的炎症反应,神经营养因子,神经递质调节和凋亡抑制。可用性的便利性,比较低的成本和安全性特征为使用该化合物作为具有巨大临床益处的有效药物提供了额外的优点。然而,越来越需要改善水飞蓟素及相关产品的生物利用度,并且需要更一致和可靠的人类试验来准确地验证该天然化合物的神经保护功效。 结论:本综述中提到的研究结果令人期待,提供了对水飞蓟素在神经变性和神经退行性疾病与疾病进展病理学相关的各种神经变性疾病中的临床相关性的深入了解。
关键词: 阿尔茨海默病,神经退行性疾病,帕金森病,水飞蓟素,神经保护作用,氧化应激。
图形摘要
Current Drug Targets
Title:A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin
Volume: 18 Issue: 13
关键词: 阿尔茨海默病,神经退行性疾病,帕金森病,水飞蓟素,神经保护作用,氧化应激。
摘要: Background: The plant milk thistle and silymarin has been traditionally used as a natural remedy for the treatment of various ailments including neurological disorders such as Alzheimer’s and Parkinson's disease and cerebral ischemia for over 2000 years.
Objective: In this article we review the neuroprotective effects of silymarin against various neurological dysfunctions. Results: The neuroprotective effects conferred by silymarin include modulation of various antioxidant mechanisms, and several kinases involved in cell signaling pathways, inhibition of the inflammatory response generated during neurodegeneration, neurotropic effects, regulation of neurotransmitters and inhibition of apoptosis. The ease of availability, comparative low cost and safety profile provide additional advantages for the use of this compound as a potent drug with immense clinical benefit. However, there is a growing need for improvements in the bioavailability of silymarin and related products, and more consistent and reliable human trials are required to accurately validate the neuroprotective efficacy of this natural compound. Conclusion: The promising outcomes of the studies mentioned in this review provide renewed insight into the clinical relevance of silymarin in a variety of neurodegenerative disorders where neuroinflammation and oxidative stress are pathologically relevant to disease progression.Export Options
About this article
Cite this article as:
A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin, Current Drug Targets 2017; 18 (13) . https://dx.doi.org/10.2174/1389450117666161227125121
DOI https://dx.doi.org/10.2174/1389450117666161227125121 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structure and Function of Poly(ADP-ribose) Polymerase-1: Role in Oxidative Stress-Related Pathologies
Current Vascular Pharmacology Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Superoxide and Post-Ischemic Liver Injury: Potential Therapeutic Target for Liver Transplantation
Current Medicinal Chemistry Old Drugs for New: Contemporary Immunosuppressant Development
Medicinal Chemistry Reviews - Online (Discontinued) Treatment Options in Alzheimer´s Disease: The GABA Story
Current Pharmaceutical Design Pharmacological Neuroprotection in Cardiac Surgery: Effectiveness of Pharmacologic-Preconditioning with Erythromycin
Current Vascular Pharmacology Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Angiotensin-Converting Enzyme Inhibitors: Mechanisms of Action and Implications In Anesthesia Practice
Current Pharmaceutical Design The Complement Cascade: New Avenues in Stroke Therapy
Current Vascular Pharmacology Cooling the Injured Brain: How Does Moderate Hypothermia Influence the Pathophysiology of Traumatic Brain Injury
Current Pharmaceutical Design “Cardiovascular” Drugs in Rheumatoid Arthritis: Killing Two Birds with One Stone?
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?
Cardiovascular & Hematological Agents in Medicinal Chemistry Protective Effects of Anesthetics on Vascular Function Related to K<sup>+</sup> Channels
Current Pharmaceutical Design Neuroprotective Role of Agmatine in Neurological Diseases
Current Neuropharmacology Non Peptidic Urotensin II Antagonists: Perspectives for a New Class of Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Gender Specific Aspects of Cell Death in the Cardiovascular System
Current Pharmaceutical Design Cellular Mechanisms of the Protective Effect of Polyphenols on the Neurovascular Unit in Strokes
Cardiovascular & Hematological Agents in Medicinal Chemistry The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke
Current Neuropharmacology Polymorphisms in TOLL-Like Receptor Genes and their Roles in Allergic Asthma and Atopy
Recent Patents on Inflammation & Allergy Drug Discovery Neutrophil Gelatinase-associated Lipocalin as a Marker of Postoperative Acute Kidney Injury Following Cardiac Surgery in Patients with Preoperative Kidney Impairment
Cardiovascular & Hematological Disorders-Drug Targets